Aug 12, 2025 17:00
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
1.32 0.91 (68.94%) | -0.03 (-1.33%) | 0.0 (0.0%) | 0.0 (0.0%) | 0.01 (0.73%) | -0.01 (-0.75%) | 0.9 (67.67%) | 0.9 (67.67%) |
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.09
- Diluted EPS:
- -0.09
- Basic P/E:
- -24.7778
- Diluted P/E:
- -24.7778
- RSI(14) 1m:
- 26.82
- VWAP:
- 2.25
- RVol:
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price decrease 1m | 2.22 -0.06 (-2.63%) | Oct 15 18:55 |
1m | Price increase 1m | 2.28 +0.03 (+1.33%) | Oct 15 18:54 |
1m | Price decrease 1m | 2.22 -0.05 (-2.2%) | Oct 15 18:51 |
10m | Price increase 10m | 2.3 +0.08 (+3.61%) | Oct 15 18:43 |
1m | Price increase 1m | 2.28 +0.04 (+1.77%) | Oct 15 18:41 |
Related News
May 08, 2025 11:16
Feb 06, 2025 10:00
Mar 27, 2024 12:14
Mar 08, 2024 18:47
Mar 08, 2024 13:23
Feb 05, 2024 17:56
Nov 27, 2023 18:41
Nov 22, 2023 19:03
Nov 20, 2023 19:35